Department of Molecular Pathology, Graduate School of Health Sciences, Dokuz Eylul University, IZMIR, TURKEY.
Department of General Surgery, Dokuz Eylul University, Faculty of Medicine, IZMIR, TURKEY.
Turk Patoloji Derg. 2024;40(2):101-108. doi: 10.5146/tjpath.2023.13161.
Alterations in the expression of several long non-coding RNAs (lncRNAs) have been shown in chronic hepatitis B-associated hepatocellular carcinoma (CHB-HCC). Here, we aimed to investigate the association between the expression of inflammation-associated lncRNA X-inactive specific transcript (XIST) and the type of inflammatory cells within the tumor microenvironment.
Twenty-one consecutive cirrhotic patients with CHB-HCC were included. XIST expression levels were investigated on formalin-fixed paraffin-embedded (FFPE) tumoral and peritumoral tissue samples by real-time polymerase chain reaction (RT-PCR). Immunohistochemical staining for CD3, CD4, CD8, CD25, CD163, CTLA4, and PD-1 were performed. The findings were statistically analyzed.
Of the 21 cases, 11 (52.4%) had tumoral and 10 (47.6%) had peritumoral XIST expression. No significant association was found between the degree of inflammation and XIST expression. The number of intratumoral CD3, CD4, CD8 and CD20 positive cells was higher in XIST-expressing tumors, albeit without statistical significance. Tumoral and peritumoral XIST expression tended to be more common in patients with tumoral and peritumoral CD4high inflammation. The number of intratumoral CD25 positive cells was significantly higher in XIST-expressing tumors (p=0.01). Tumoral XIST expression was significantly more common in intratumoral CD25high cases (p=0.04). Peritumoral XIST expression was also more common among patients with CD25high peritumoral inflammation, albeit without statistical significance (p=0.19).
lncRNA XIST is expressed in CHB-HCC and its expression is significantly associated with the inflammatory tumor microenvironment, particularly with the presence and number of CD25 (+) regulatory T cells. In vitro studies are needed to explore the detailed mechanism.
多项研究表明,慢性乙型肝炎相关肝细胞癌(CHB-HCC)中存在几种长链非编码 RNA(lncRNA)表达的改变。本研究旨在探讨肿瘤微环境中炎症相关 lncRNA X 染色体失活特异转录物(XIST)表达与肿瘤内炎症细胞类型之间的关系。
共纳入 21 例连续的 CHB-HCC 肝硬化患者。采用实时聚合酶链反应(RT-PCR)检测肿瘤及肿瘤旁组织石蜡固定包埋(FFPE)样本中 XIST 的表达水平。进行 CD3、CD4、CD8、CD25、CD163、CTLA4 和 PD-1 的免疫组织化学染色。对检测结果进行统计学分析。
21 例患者中,11 例(52.4%)肿瘤组织和 10 例(47.6%)肿瘤旁组织存在 XIST 表达。炎症程度与 XIST 表达之间无显著相关性。XIST 表达肿瘤组织中 CD3、CD4、CD8 和 CD20 阳性细胞数量较高,但无统计学意义。肿瘤和肿瘤旁组织 XIST 表达在肿瘤和肿瘤旁 CD4 高炎症患者中更为常见。XIST 表达肿瘤组织中 CD25 阳性细胞数量显著较高(p=0.01)。肿瘤组织中 CD25 高表达病例中 XIST 表达更为常见(p=0.04)。肿瘤旁 CD25 高表达炎症患者中也更常见肿瘤旁 XIST 表达,但无统计学意义(p=0.19)。
lncRNA XIST 在 CHB-HCC 中表达,其表达与炎症肿瘤微环境显著相关,特别是与 CD25(+)调节性 T 细胞的存在和数量相关。需要进行体外研究以探讨其详细机制。